Correlation Between Solid Biosciences and Syndax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Solid Biosciences and Syndax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Solid Biosciences and Syndax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Solid Biosciences LLC and Syndax Pharmaceuticals, you can compare the effects of market volatilities on Solid Biosciences and Syndax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Solid Biosciences with a short position of Syndax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Solid Biosciences and Syndax Pharmaceuticals.
Diversification Opportunities for Solid Biosciences and Syndax Pharmaceuticals
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Solid and Syndax is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Solid Biosciences LLC and Syndax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syndax Pharmaceuticals and Solid Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Solid Biosciences LLC are associated (or correlated) with Syndax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syndax Pharmaceuticals has no effect on the direction of Solid Biosciences i.e., Solid Biosciences and Syndax Pharmaceuticals go up and down completely randomly.
Pair Corralation between Solid Biosciences and Syndax Pharmaceuticals
Given the investment horizon of 90 days Solid Biosciences LLC is expected to generate 2.18 times more return on investment than Syndax Pharmaceuticals. However, Solid Biosciences is 2.18 times more volatile than Syndax Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Syndax Pharmaceuticals is currently generating about 0.0 per unit of risk. If you would invest 632.00 in Solid Biosciences LLC on August 31, 2024 and sell it today you would lose (62.00) from holding Solid Biosciences LLC or give up 9.81% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Solid Biosciences LLC vs. Syndax Pharmaceuticals
Performance |
| Timeline |
| Solid Biosciences LLC |
| Syndax Pharmaceuticals |
Solid Biosciences and Syndax Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Solid Biosciences and Syndax Pharmaceuticals
The main advantage of trading using opposite Solid Biosciences and Syndax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Solid Biosciences position performs unexpectedly, Syndax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syndax Pharmaceuticals will offset losses from the drop in Syndax Pharmaceuticals' long position.| Solid Biosciences vs. Century Therapeutics | Solid Biosciences vs. Edgewise Therapeutics | Solid Biosciences vs. C4 Therapeutics | Solid Biosciences vs. Mineralys Therapeutics, Common |
| Syndax Pharmaceuticals vs. Cogent Biosciences | Syndax Pharmaceuticals vs. Cullinan Oncology LLC | Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | Syndax Pharmaceuticals vs. Mersana Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |